4//SEC Filing
Holuka Eugene Myron 4
Accession 0001213900-24-074506
CIK 0001506251other
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 4:01 PM ET
Size
23.2 KB
Accession
0001213900-24-074506
Insider Transaction Report
Form 4
Holuka Eugene Myron
Director
Transactions
- Tax Payment
Common Stock
2024-03-13$0.75/sh−48$36→ 2,367 total - Exercise/Conversion
Stock Option (Right to Purchase Common Stock)
2024-03-13−2,415→ 0 totalExercise: $0.01From: 2017-04-14Exp: 2024-04-14→ Common Stock (2,415 underlying) - Exercise/Conversion
Common Stock
2024-03-13$0.01/sh+2,415$36→ 2,415 total
Holdings
- 75,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.70Exp: 2033-10-10→ Common Stock (75,000 underlying) - 75,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.04Exp: 2031-10-11→ Common Stock (75,000 underlying) - 15,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.00Exp: 2031-07-22→ Common Stock (15,000 underlying) - 25,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.69Exp: 2031-02-16→ Common Stock (25,000 underlying) - 15,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.62Exp: 2028-09-04→ Common Stock (15,000 underlying) - 35,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.01Exp: 2030-10-06→ Common Stock (35,000 underlying) - 25,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.39Exp: 2030-07-07→ Common Stock (25,000 underlying) - 10,000
Stock Option (Right to Purchase Common Stock)
Exercise: $3.45Exp: 2027-09-13→ Common Stock (10,000 underlying) - 13,334
Stock Option (Right to Purchase Common Stock)
Exercise: $12.00Exp: 2026-06-23→ Common Stock (13,334 underlying) - 75,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.25Exp: 2032-10-04→ Common Stock (75,000 underlying) - 25,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.67Exp: 2029-10-08→ Common Stock (25,000 underlying)
Footnotes (11)
- [F1]The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
- [F10]The options vested in full on September 13, 2018.
- [F11]The options vested in full on June 23, 2017.
- [F2]The options vested in full on October 4, 2023.
- [F3]The options vested in full on October 11, 2022.
- [F4]The options vested in full on July 22, 2022.
- [F5]The options vested in full on February 16, 2022.
- [F6]The options vested in full on October 6, 2021.
- [F7]The options vested in full on July 7, 2021.
- [F8]The options vested in full on October 8, 2020.
- [F9]The options vested in full on September 4, 2019.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Entity typeother
Related Parties
1- filerCIK 0001678292
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 4:01 PM ET
- Size
- 23.2 KB